MicroRNA control of epithelial-mesenchymal transition and metastasis.
about
miRNAs Signature in Head and Neck Squamous Cell Carcinoma Metastasis: A Literature ReviewMicroRNA aberrations: An emerging field for gallbladder cancer managementMicroRNA Regulation of Epithelial to Mesenchymal TransitionExosomes as potent regulators of HCC malignancy and potential bio-tools in clinical applicationHelicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesisThe role of EMT and MET in cancer disseminationEmerging therapeutic biomarkers in endometrial cancerRegulation of mesenchymal phenotype by MicroRNAs in cancerZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistanceThe emerging molecular machinery and therapeutic targets of metastasismiR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasionThe crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticityNovel genes associated with lymph node metastasis in triple negative breast cancerMicroRNA-590 is an EMT-suppressive microRNA involved in the TGFβ signaling pathway.Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to FibrosismiR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer.miR-590 regulates WT1 during proliferation of G401 cellsMiR-155 up-regulated by TGF-β promotes epithelial-mesenchymal transition, invasion and metastasis of human hepatocellular carcinoma cells in vitro.New insights into the role of EMT in tumor immune escape.miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression.Adult-specific functions of animal microRNAs.MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasisID1 promotes breast cancer metastasis by S100A9 regulation.Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerDe-SUMOylation of FOXC2 by SENP3 promotes the epithelial-mesenchymal transition in gastric cancer cells.Novel clinical therapeutics targeting the epithelial to mesenchymal transitionImpact of soy isoflavones on the epigenome in cancer prevention.MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway.miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.microRNA as a potential vector for the propagation of robustness in protein expression and oscillatory dynamics within a ceRNA networkMetastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivityConnecting the dots: chromatin and alternative splicing in EMT.Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcriptsTargeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).Proteomics for understanding miRNA biology.Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivoMiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
P2860
Q26747138-3A9A6538-A130-4CF2-B9C1-512CEB4E1426Q26768416-E1AD0D5E-2B40-4429-ADF9-0D666E824639Q26771110-BCF0CCA6-6629-4AD1-A6C1-99C23D07F63EQ26771839-B8666EDA-A50F-40B7-8F08-A0F2CC25643EQ26775839-2548196F-E4C3-456F-A975-32524F8B6272Q26796298-47165DA4-1FED-4854-B4DC-85568F186F47Q26865904-633DDF13-0935-4756-ACBB-224FF3024982Q27009506-726B6C8D-A954-4556-8A61-17A16D3F346AQ27015111-33FDCE64-25B5-49C4-860D-E2D41D211901Q27022207-FE37B8BA-4DF3-4458-BAB3-3E15E558C52DQ27316744-4C25DE53-5561-4E28-9AEA-B45F4210B414Q28070337-68EAFB5F-1CC2-4121-9C72-C31A2BE94C9DQ28393204-49E9E6D0-F5C2-481B-803D-748EC875A453Q29347525-0969C10D-A1BC-46A0-9A3A-6F56FF602C45Q33800254-F999AB06-85A7-4321-AA60-D74BA370BE2DQ33822461-864D0A88-E6EC-4FB1-A82D-80CBAC8DD3BCQ33827922-AC230B02-7A8A-459E-8A48-16ADCECAD43EQ33850292-B02D2C3C-8284-4B58-BB5F-2C2BC6CF97A9Q33869781-97170290-2953-4742-9EDB-25F680C6F572Q33980238-A20EB0AE-D552-438A-918B-1FBEDB4EDC67Q34061489-3109122D-8752-444A-BDDD-CBDBA249F007Q34139798-11B4C7AC-C298-4329-B025-3794B73E2837Q34177858-B04C9DB1-3810-431D-A685-B8743BB373F7Q34295621-8F5C1B62-E62B-49ED-886E-B552284F6845Q34334509-738D5830-4DF9-4994-A103-510D3C3EDF8DQ34345818-034B1F6C-0657-4A52-81F2-FDEBE6207BF3Q34411665-0CF0EC29-8921-4C44-826C-263905AAFE64Q34418312-9D61A791-8D52-4889-8B39-47A932AC7F3EQ34729876-A3CF10E7-8408-4A0C-BED3-ABB6DC29A6FAQ34786582-52772AA3-49A2-4AF4-88E5-2EE370C228E0Q34880376-E4C0F9BF-D971-4A60-A4C2-12C8D0ECDC4BQ35078061-5ADCA4B9-EBE4-4D16-B529-D179781D9994Q35203556-A7CBC031-4040-4BE1-AA81-D29673FFDE06Q35961794-866F21A0-D791-4901-AFFF-587A9BC0A33AQ36441240-347910F2-C782-4081-B6F9-57A0CAB23CB4Q36603853-44336A40-9949-417F-B95A-4C582072ED31Q36992190-71BE014E-8D1F-4F09-8F1A-9923BF0DCA49Q37023687-83567335-07BC-4E75-8C7C-BF5F0E3A1DE7Q37107787-9B410CBA-341E-4798-B241-1EE34434D400Q37190321-C6E6AB48-D90D-4837-A834-C8AF4CE1A901
P2860
MicroRNA control of epithelial-mesenchymal transition and metastasis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MicroRNA control of epithelial-mesenchymal transition and metastasis.
@en
type
label
MicroRNA control of epithelial-mesenchymal transition and metastasis.
@en
prefLabel
MicroRNA control of epithelial-mesenchymal transition and metastasis.
@en
P2860
P1476
MicroRNA control of epithelial-mesenchymal transition and metastasis
@en
P2093
P2860
P2888
P304
P356
10.1007/S10555-012-9368-6
P577
2012-12-01T00:00:00Z
P6179
1009909753